The Magnetic Resonance Imaging and Spectroscopy (MRIS) Facility provides support for imaging of cells, materials, tissues, small animals, patients, and volunteers. The Facility serves primarily UCCRC investigators, but also investigators in other areas of research. A variety of in vitro and in vivo measurements are offered including: (a) Pre-clinical and clinical evaluation of the effects of novel therapies based on tumor volume, morphology, perfusion, capillary permeability, cell viability from diffusion-sensitive imaging, and other measurements;(b) High resolution imaging of tissue samples;(c) Pre-clinical and clinical development and testing of new imaging methods for early detection and evaluation of cancer, for example novel approaches to Dynamic Contrast Enhanced MRI (DCEMRI) and spectral/spatial imaging;(d) Imaging of cells and tissues in culture;and (e) Development and testing of image-guided therapies including high intensity focused ultrasound. The Facility has an experienced staff. Together the Co-Directors, Drs. Greg Karczmar and Brian Roman provide expertise in MRI physics and technology, cancer imaging, and applications of MRI to study molecular biology and physiology. The Clinical Co-Director, Dr. Mitchell, is an experienced Radiologist with clinical trials expertise. The experienced staff includes Technical Directors for clinical and pre-clinical imaging, a Facility Manager with over 15 years of MRI experience, a Senior Veterinary Technologist with 25 years of experience, and a talented group of technologists and MRI physicists. Collaborative interdisciplinary and translational research is emphasized. For example, the MRIS Core provides support for the recently funded Breast Cancer SPORE, directed by Dr. Olufunmilayo Olopade. In 2007, the resources available to the Facility will be dramatically upgraded. A new state-of-the-art 9.4 Tesla small bore scanner will be installed in the Lynn S. Florsheim MRIS Laboratory, and this scanner will be used for pre-clinical research. This new scanner will significantly increase the spatial resolution and/or signal-to-noise ratio, and also the range of experiments that can be performed. In addition, a new 1.5 Tesla whole body research scanner will dramatically increase the capacity for clinical research. At the same time, the MRIS staff will be increased to include a Nurse Coordinator, and additional MRI technologists, to accommodate the increased volume of research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-37
Application #
8375711
Study Section
Special Emphasis Panel (ZCA1-RTRB-N)
Project Start
Project End
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
37
Fiscal Year
2012
Total Cost
$139,646
Indirect Cost
$48,815
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Girard, Romuald; Zeineddine, Hussein A; Koskimäki, Janne et al. (2018) Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res 122:1716-1721
Day, Kasey J; Casler, Jason C; Glick, Benjamin S (2018) Budding Yeast Has a Minimal Endomembrane System. Dev Cell 44:56-72.e4
Pu, Jinyue; Kentala, Kaitlin; Dickinson, Bryan C (2018) Multidimensional Control of Cas9 by Evolved RNA Polymerase-Based Biosensors. ACS Chem Biol 13:431-437
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Liu, Hongtao; Zha, Yuanyuan; Choudhury, Noura et al. (2018) WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Exp Hematol Oncol 7:1
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898
Ferreira, Caroline M; Williams, Jesse W; Tong, Jiankun et al. (2018) Allergen Exposure in Lymphopenic Fas-Deficient Mice Results in Persistent Eosinophilia Due to Defects in Resolution of Inflammation. Front Immunol 9:2395
Luke, Jason J; Lemons, Jeffrey M; Karrison, Theodore G et al. (2018) Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 36:1611-1618
Wang, Amy Y; Weiner, Howard; Green, Margaret et al. (2018) A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. J Hematol Oncol 11:4
Sample, Ashley; He, Yu-Ying (2018) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34:13-24

Showing the most recent 10 out of 668 publications